Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations.
作者信息
Kondili Loreta A, Quaranta Maria Giovanna, Andreoni Massimo
机构信息
National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Unicamillus International Medical University in Rome, Rome, Italy.
出版信息
Lancet Reg Health Eur. 2025 Jan 21;49:101222. doi: 10.1016/j.lanepe.2025.101222. eCollection 2025 Feb.
Abstract
摘要
相似文献
1
Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations.
Lancet Reg Health Eur. 2025 Jan 21;49:101222. doi: 10.1016/j.lanepe.2025.101222. eCollection 2025 Feb.
2
HBV and HCV testing outcomes among marginalized communities in Italy, 2019-2024: a prospective study.
Lancet Reg Health Eur. 2024 Dec 9;49:101172. doi: 10.1016/j.lanepe.2024.101172. eCollection 2025 Feb.
3
Bridging Innovation and Equity: Advancing Public Health Through Just-in-Time Adaptive Interventions.
Annu Rev Public Health. 2025 Apr;46(1):43-68. doi: 10.1146/annurev-publhealth-071723-103909. Epub 2024 Dec 10.
4
Advancing health equity through social care interventions.
Health Serv Res. 2023 Dec;58 Suppl 3(Suppl 3):318-326. doi: 10.1111/1475-6773.14244.
5
Promoting Health Equity Among Marginalized and Vulnerable Populations.
Nurs Clin North Am. 2024 Mar;59(1):109-120. doi: 10.1016/j.cnur.2023.11.009. Epub 2023 Dec 14.
6
The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets.
Viruses. 2025 Feb 14;17(2):265. doi: 10.3390/v17020265.
7
A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
World J Gastroenterol. 2007 Mar 28;13(12):1770-87. doi: 10.3748/wjg.v13.i12.1770.
8
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5.
9
Advancing Health Equity Efforts to Reduce Obesity: Changing the Course.
Annu Rev Nutr. 2022 Aug 22;42:453-480. doi: 10.1146/annurev-nutr-092021-050805. Epub 2022 Apr 13.
10
The Challenge of Advancing Health Equity During a Year of Pandemic and Crisis: Our Organization's Response.
Nurs Adm Q. 2022;46(2):154-166. doi: 10.1097/NAQ.0000000000000521.
本文引用的文献
1
HBV and HCV testing outcomes among marginalized communities in Italy, 2019-2024: a prospective study.
Lancet Reg Health Eur. 2024 Dec 9;49:101172. doi: 10.1016/j.lanepe.2024.101172. eCollection 2025 Feb.
2
Benchmarking of an Intervention Aiming at the Micro-Elimination of Hepatitis C in Vulnerable Populations in Perpignan, France, to Inform Scale-Up and Elimination on the French Territory.
Viruses. 2024 Oct 21;16(10):1645. doi: 10.3390/v16101645.
3
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy.
Infect Dis Poverty. 2024 May 28;13(1):39. doi: 10.1186/s40249-024-01200-9.
4
Inequities in primary liver cancer in Europe: The state of play.
J Hepatol. 2024 Apr;80(4):645-660. doi: 10.1016/j.jhep.2023.12.031. Epub 2024 Jan 17.
5
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
J Infect Dis. 2023 Sep 13;228(Suppl 3):S211-S220. doi: 10.1093/infdis/jiad038.
6
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Lancet Gastroenterol Hepatol. 2023 Oct;8(10):879-907. doi: 10.1016/S2468-1253(23)00197-8. Epub 2023 Jul 27.
7
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care.
Liver Int. 2022 Feb;42(2):309-319. doi: 10.1111/liv.15095. Epub 2021 Nov 17.
8
Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness.
Open Forum Infect Dis. 2021 Sep 25;8(10):ofab488. doi: 10.1093/ofid/ofab488. eCollection 2021 Oct.
9
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
Dig Liver Dis. 2022 Feb;54(2):237-242. doi: 10.1016/j.dld.2021.03.026. Epub 2021 Apr 27.
Zotero 插件